KKR, a prominent investment firm, has signed agreements to purchase Healthium MedTech Ltd., a top Indian medical devices company, from Apax-affiliated funds. Healthium, offering a broad spectrum of surgical products globally, was transformed from a local sutures provider to a global leader by Apax since 2018. The company, with its comprehensive product portfolio in wound closure, arthroscopy, and advanced wound care, extended its global presence from 50 to over 90 countries. Anish Bafna (CEO) and Vishal Maheshwari (CFO) have been instrumental in this growth. KKR’s acquisition aligns with their healthcare expansion in Asia Pacific, continuing investments like JB Pharmaceuticals, Max Healthcare, and others. KKR utilized its Asian Fund IV for this transaction, which is set to complete in Q3 2024. Regulatory approvals are pending and financial terms were undisclosed. Advisors for the deal included Jefferies LLC and Kirkland & Ellis LLP for Apax and Healthium, and Moelis & Company, Simpson Thacher & Bartlett, and AZB & Partners for KKR.

Private Equity, Healthcare, Medical Devices,India, Global